Blood test identified as a good biomarker for idiopathic PAH

Robyn Kalda
5 days ago
1 min read

A relatively simple, inexpensive, and minimally invasive test for idiopathic pulmonary arterial hypertension (IPAH) would aid in the diagnosis of this disease. This study found that levels of the NOTCH3 extracellular domain (NOTCH3-ECD) shed into blood serum could be used as a biomarker for IPAH. They found that NOTCH3-ECD levels did correlate with the presence and severity of IPAH.

Read the Nature Medicine article

Recent Posts

Doctors and patients recognize PAH symptom severity differently

As pulmonary arterial hypertension (PAH) patients became sicker, their self-reported quality of life was significantly worse than their doctors recognized. This discordance was associated both with wo

Racial and ethnic equity in PAH clinical trials

Looking at the racial and ethnic breakdown of patients with PAH and patients who take part in clinical trials, the authors conclude that the goal of equitable representation has not yet been reached.

Air pollution may worsen PAH

Air pollution is known to be bad for heart and lung diseases, but this study looked at whether it affected pulmonary arterial hypertension (PAH) in particular. They followed a cohort of patients for a

Comments